- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04418700
Effects of the Breath Stacking Technique After Upper Abdominal Surgery
April 23, 2021 updated by: Prof. Dr. Antônio Marcos Vargas da Silva, Universidade Federal de Santa Maria
Effects of the Breath Stacking Technique After Upper Abdominal Surgery: Randomized Controlled Trial
This study evaluates the effects of the breath stacking technique in patients after upper abdominal surgery.
Half of the patients receive routine physical therapy associated with the Breath Stacking technique, while the other half will receive only routine physical therapy.
Study Overview
Detailed Description
This randomized controlled study aims to evaluate the effects of the Breath Stacking technique in patients undergoing upper abdominal surgery on clinical, physiological and cardiopulmonary variables.
These individuals were randomized to compose the control group (CG) and the intervention group (GBS).
The routine physical therapy was performed in both groups and in the GBS two daily sessions of up to 20 minutes of Breath Stacking technique were applied.
To verify the effect of this intervention, before and after the protocol, patients underwent the following evaluations: algometry, cirtometry in the axillary line , umbilical line and the xiphoid process, ventilometry, spirometry and manovacuometry.
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rio Grande Do Sul
-
Santa Maria, Rio Grande Do Sul, Brazil, 97105-900
- Federal University of Santa Maria
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 63 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients undergoing a surgical procedure that involves in an incision in the upper quadrants of the abdominal region.
Exclusion Criteria:
- Intolerance to the use of BS mask.
- Chronic obstructive pulmonary disease (COPD), Asthma, Chron's disease.
- Liver trauma severe with hemodynamic repercussions.
- Patients undergoing esophagectomy.
- Sepsis with complications postoperative hemodynamics.
- Need for surgical reintervention.
- Forwarded to Intensive Care Unit or need for mechanical ventilation after discharge from the anesthetic recovery.
- Cognitive dysfunction that makes it impossible to understand and execute evaluations and intervention.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Breath Stacking technique
The intervention group will receive routine physical therapy associated with the Breath Stacking technique in 2 daily sessions of up to 20 minutes. The technique consists of an Instrument composed of a one-way valve coupled to a face mask to promote the accumulation of successive inspiratory volumes. |
The patients will perform the maneuver through successive inspiratory efforts for 20 s.
Subsequently, the expiratory branch will be unobstructed to allow expiration.
This maneuver will be repeated 5 times in each series, with intervals of 30 seconds between them.
The technique will be performed with the trunk inclined 30º in relation to the horizontal plane, in 3 series, with interval of 2 min completing 15 min of therapy.
|
No Intervention: Routine physical therapy
The control group will receive only routine physical therapy.
Routine physiotherapy consists of breathing exercises, using techniques bronchial hygiene and pulmonary reexpansion, and motor physiotherapy through exercise passive, active-assisted or active mobilization, stretching, training activities of daily living, positioning and removal of the bed and guidelines for post-discharge.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from second postoperative day forced vital capacity (FVC) at 7th postoperative day or hospital discharge.
Time Frame: The change in FVC will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
The FVC will be evaluated as recommended by the American Thoracic Society and European Respiratory Society (2006) and based on reproducibility and acceptability criteria, three maneuvers will be performed (variability <5%) and considered the best curve for the study.
|
The change in FVC will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
Change from second postoperative day tidal volume at 7th postoperative day or hospital discharge.
Time Frame: The change in tidal volume will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
Tidal volume will be obtained through the division of the minute volume by the respiratory rate.
|
The change in tidal volume will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heart rate
Time Frame: It will be evaluated on the 2nd postoperative day and up to 7th postoperative day. This variable will also be measured before and after the first and last BS session.
|
It will be evaluated with portable pulse oximeter.
|
It will be evaluated on the 2nd postoperative day and up to 7th postoperative day. This variable will also be measured before and after the first and last BS session.
|
Respiratory rate
Time Frame: It will be evaluated on the 2nd postoperative day and up to 7th postoperative day. This variable will also be measured before and after the first and last BS session.
|
The respiratory rate will be measured by the movements of the rib cage during respiratory cycles performed in one minute.
|
It will be evaluated on the 2nd postoperative day and up to 7th postoperative day. This variable will also be measured before and after the first and last BS session.
|
Blood pressure
Time Frame: These will be evaluated on the 2nd postoperative day and up to 7th postoperative day. These will also be measured before and after the first and last BS session.
|
Systolic and diastolic blood pressure will be verified by a stethoscope and sphygmomanometer.
|
These will be evaluated on the 2nd postoperative day and up to 7th postoperative day. These will also be measured before and after the first and last BS session.
|
Peripheral oxygen saturation (SpO2)
Time Frame: It will be evaluated on the 2nd postoperative day and up to 7th postoperative day. This variable will also be measured before and after the first and last BS session.
|
It will be evaluated with portable pulse oximeter.
|
It will be evaluated on the 2nd postoperative day and up to 7th postoperative day. This variable will also be measured before and after the first and last BS session.
|
Painful perception in the surgical incision
Time Frame: It will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
The digital algometer will be used, which constitutes a dynamometer that exerts pressure with a rubber tip 1 cm in diameter on the skin, at a 90º angle, determining the pain threshold.
|
It will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
Thoracoabdominal mobility
Time Frame: It will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
The measuring tape will be positioned in three anatomical points: axillary fold, xiphoid appendix and umbilical line.
The measurements will be performed at rest, after maximum inspiration and after maximum expiration.
|
It will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
Minute volume
Time Frame: It will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
To obtain the minute volume (MV), the patient will be instructed to inhale and exhale slowly using the Wright ® ventilometer (British Oxygen Company, London, England).
|
It will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
Forced expiratory volume in the first second (FEV1)
Time Frame: It will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
It will be evaluated as recommended by the American Thoracic Society and European Respiratory Society (2006) and based on reproducibility and acceptability criteria, three maneuvers will be performed (variability <5%) and considered the best curve for the study.
|
It will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
FEV1 / FVC ratio (FEV1 / FVC)
Time Frame: It will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
It will be evaluated as recommended by the American Thoracic Society and European Respiratory Society (2006) and based on reproducibility and acceptability criteria, three maneuvers will be performed (variability <5%) and considered the best curve for the study.
|
It will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
Peak expiratory flow (PEF)
Time Frame: It will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
It will be evaluated as recommended by the American Thoracic Society and European Respiratory Society (2006) and based on reproducibility and acceptability criteria, three maneuvers will be performed (variability <5%) and considered the best curve for the study.
|
It will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
Forced expiratory flow between 25 and 75% of the curve of FVC (FEF25-75)
Time Frame: It will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
It will be evaluated as recommended by the American Thoracic Society and European Respiratory Society (2006) and based on reproducibility and acceptability criteria, three maneuvers will be performed (variability <5%) and considered the best curve for the study.
|
It will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
Respiratory muscle strength
Time Frame: These will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
The maximal inspiratory and expiratory pressures will be evaluated with manovacuometer.
|
These will be evaluated on the 2nd postoperative day and up to 7th postoperative day.
|
Degree of dyspnea
Time Frame: It will be evaluated before and after the application of the BS technique (therefore, only in GBS) on the 2nd postoperative day and up to 7th postoperative day.
|
It will be evaluated using the modified Borg Scale, a vertical scale quantified from 0 to 10. Zero represents no symptoms and 10 represents the maximum of symptoms.
|
It will be evaluated before and after the application of the BS technique (therefore, only in GBS) on the 2nd postoperative day and up to 7th postoperative day.
|
Rates of signs of respiratory discomfort (dizziness, tachypnea, sweating, use accessory musculature)
Time Frame: These will be evaluated before and after the application of the BS technique (therefore, only in GBS) on the 2nd postoperative day and up to 7th postoperative day.
|
Evaluated through clinical inspection.
|
These will be evaluated before and after the application of the BS technique (therefore, only in GBS) on the 2nd postoperative day and up to 7th postoperative day.
|
Rates of gastrointestinal symptoms (pain abdominal, nausea, vomiting)
Time Frame: These will be evaluated before and after the application of the BS technique (therefore, only in GBS) on the 2nd postoperative day and up to 7th postoperative day.
|
Evaluated through clinical inspection.
|
These will be evaluated before and after the application of the BS technique (therefore, only in GBS) on the 2nd postoperative day and up to 7th postoperative day.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2020
Primary Completion (Actual)
March 31, 2021
Study Completion (Actual)
March 31, 2021
Study Registration Dates
First Submitted
May 21, 2020
First Submitted That Met QC Criteria
June 2, 2020
First Posted (Actual)
June 5, 2020
Study Record Updates
Last Update Posted (Actual)
April 26, 2021
Last Update Submitted That Met QC Criteria
April 23, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 11041019.0.0000.5346
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Surgery
-
University Hospital MuensterCompletedAbdominal Surgery | Abdominothoracic SurgeryGermany
-
3MRecruitingAbdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular SurgeryUnited States
-
York Teaching Hospitals NHS Foundation TrustCompletedColorectal Surgery | Major Abdominal SurgeryUnited Kingdom
-
Technische Universität DresdenRecruiting
-
The Cleveland ClinicRecruiting
-
Washington University School of MedicineTerminatedAbdominal SurgeryUnited States
-
Sameh FathyCompleted
-
The Cleveland ClinicWithdrawnAbdominal Surgery
-
Bayside HealthNational Health and Medical Research Council, AustraliaCompletedAbdominal SurgeryAustralia
-
Hospices Civils de LyonUnknown
Clinical Trials on Breath Stacking
-
Brazilian Institute of Higher Education of CensaCompletedMechanical Ventilation | Lung InfectionBrazil
-
Federal University of Health Science of Porto AlegreCompleted
-
Federal University of UberlandiaCompletedHemodynamic Instability
-
Universidade Federal de PernambucoConselho Nacional de Desenvolvimento Científico e TecnológicoUnknown
-
Universidade Federal do Rio de JaneiroCompletedFunctional Disturbance Following Cardiac SurgeryBrazil
-
Universidade Federal de PernambucoCompleted
-
Universidade Federal de Santa MariaCompletedComplication, Postoperative | Cardiac ComplicationBrazil
-
Federal University of São PauloUnknown
-
Cairo UniversityCompletedCough | Mechanical Ventilation Complication | Intensive Care Unit Acquired Weakness | Ineffective Airway Clearance | Diaphragm IssuesEgypt
-
Escola Superior de Ciencias da SaudeTerminatedNeuromuscular Diseases | Amyotrophic Lateral SclerosisBrazil